Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders

Int J Mol Sci. 2024 Mar 6;25(5):3079. doi: 10.3390/ijms25053079.

Abstract

Advanced Therapy Medicinal Products (ATMPs) comprise a heterogenous class of innovative medicinal products, which further require extensive preclinical and clinical assessments before their broader use in the general population [...].

Publication types

  • Editorial

MeSH terms

  • COVID-19*
  • Cell- and Tissue-Based Therapy
  • Genetic Therapy
  • Humans

Grants and funding

This research received no external funding.